BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Tanase CP, Neagu AI, Necula LG, Mambet C, Enciu AM, Calenic B, Cruceru ML, Albulescu R. Cancer stem cells: Involvement in pancreatic cancer pathogenesis and perspectives on cancer therapeutics. World J Gastroenterol 2014; 20(31): 10790-10801 [PMID: 25152582 DOI: 10.3748/wjg.v20.i31.10790]
URL: https://www.wjgnet.com/1948-5204/full/v20/i31/10790.htm
Number Citing Articles
1
Mohamed J. Saadh, Hala Baher, Yuanji Li, Mvnl chaitanya, José Luis Arias-Gonzáles, Omer Qutaiba B. Allela, Mohammed H. Mahdi, Juan Carlos Cotrina-Aliaga, Natrayan Lakshmaiya, Salam Ahjel, Ali H. Amin, Gregorio Gilmer Rosales Rojas, Fuad Ameen, Muhammad Ahsan, Reza Akhavan-Sigari. The bioengineered and multifunctional nanoparticles in pancreatic cancer therapy: Bioresponisive nanostructures, phototherapy and targeted drug deliveryEnvironmental Research 2023; 233: 116490 doi: 10.1016/j.envres.2023.116490
2
Yan-Bo Zheng, Meng-Ran Zhang, Yi Li, Xiu-Jun Liu, Yong-Su Zhen. DBDx-based drug combinations show highly potent therapeutic efficacy against human pancreatic cancer xenografts in athymic miceCancer Biology & Therapy 2020; 21(8): 749 doi: 10.1080/15384047.2020.1776580
3
Esther Pilar García-Santos, David Padilla-Valverde, Pedro Villarejo-Campos, Cristina Murillo-Lázaro, Esther Fernández-Grande, Teodoro Palomino-Muñoz, Marta Rodríguez-Martínez, Mariano Amo-Salas, Paloma Nuñez-Guerrero, Susana Sánchez-García, Alejandro Puerto-Puerto, Jesús Martín-Fernández. The utility of hyperthermic intra-abdominal chemotherapy with gemcitabine for the inhibition of tumor progression in an experimental model of pancreatic peritoneal carcinomatosis, in relation to their behavior with pancreatic cancer stem cells CD133+ CXCR4+Pancreatology 2016; 16(4): 632 doi: 10.1016/j.pan.2016.04.031
4
Haiyong Wang, Zhouyu Ning, Yingyi Li, Xiaoyan Zhu, Zhiqiang Meng. Bufalin suppresses cancer stem-like cells in gemcitabine-resistant pancreatic cancer cells via Hedgehog signalingMolecular Medicine Reports 2016; 14(3): 1907 doi: 10.3892/mmr.2016.5471
5
Aoife S Crawley, Richard J O’Kennedy. The need for effective pancreatic cancer detection and management: a biomarker-based strategyExpert Review of Molecular Diagnostics 2015; 15(10): 1339 doi: 10.1586/14737159.2015.1083862
6
Elena Montano, Alessandra Pollice, Valeria Lucci, Geppino Falco, Ornella Affinito, Girolama La Mantia, Maria Vivo, Tiziana Angrisano. Pancreatic Progenitor Commitment Is Marked by an Increase in Ink4a/Arf ExpressionBiomolecules 2021; 11(8): 1124 doi: 10.3390/biom11081124
7
Joo Kyung Park, Yejin Kim, Hyemin Kim, Jane Jeon, Tae Wan Kim, Ji-Hong Park, Young-il Hwnag, Wang Jae Lee, Jae Seung Kang. The anti-fibrotic effect of GV1001 combined with gemcitabine on treatment of pancreatic ductal adenocarcinomaOncotarget 2016; 7(46): 75081 doi: 10.18632/oncotarget.12057
8
Cristiana Tanase, Ancuta-Augustina Gheorghisan-Galateanu, Ionela Daniela Popescu, Simona Mihai, Elena Codrici, Radu Albulescu, Mihail Eugen Hinescu. CD36 and CD97 in Pancreatic Cancer versus Other MalignanciesInternational Journal of Molecular Sciences 2020; 21(16): 5656 doi: 10.3390/ijms21165656
9
T.Y.S. Le Large, M.F. Bijlsma, G. Kazemier, H.W.M. van Laarhoven, E. Giovannetti, C.R. Jimenez. Key biological processes driving metastatic spread of pancreatic cancer as identified by multi-omics studiesSeminars in Cancer Biology 2017; 44: 153 doi: 10.1016/j.semcancer.2017.03.008
10
Hsing-Ju Wu, Pei-Yi Chu. Role of Cancer Stem Cells in Cholangiocarcinoma and Therapeutic ImplicationsInternational Journal of Molecular Sciences 2019; 20(17): 4154 doi: 10.3390/ijms20174154
11
Maurizio Romano, Francesco De Francesco, Enrico Gringeri, Antonio Giordano, Giuseppe A. Ferraro, Marina Di Domenico, Umberto Cillo. Tumor Microenvironment Versus Cancer Stem Cells in Cholangiocarcinoma: Synergistic Effects?Journal of Cellular Physiology 2016; 231(4): 768 doi: 10.1002/jcp.25190
12
Caixia Liang, Tomohiko Fukuda, Tomoya Isaji, Chengwei Duan, Wanli Song, Yuqin Wang, Jianguo Gu. α1,6-Fucosyltransferase contributes to cell migration and proliferation as well as to cancer stemness features in pancreatic carcinomaBiochimica et Biophysica Acta (BBA) - General Subjects 2021; 1865(6): 129870 doi: 10.1016/j.bbagen.2021.129870
13
Sergey Koshkin, Anna Danilova, Grigory Raskin, Nikolai Petrov, Olga Bajenova, Stephen J. O’Brien, Alexey Tomilin, Elena Tolkunova. Primary cultures of human colon cancer as a model to study cancer stem cellsTumor Biology 2016; 37(9): 12833 doi: 10.1007/s13277-016-5214-8
14
Li‐Juan Zhao, Ying‐Ying Li, Yu‐Tong Zhang, Qi‐Qi Fan, Hong‐Mei Ren, Cheng Zhang, Adil Mardinoglu, Wen‐Chao Chen, Jing‐Ru Pang, Dan‐Dan Shen, Jun‐Wei Wang, Long‐Fei Zhao, Jian‐Ying Zhang, Zhen‐Ya Wang, Yi‐Chao Zheng, Hong‐Min Liu. Lysine demethylase LSD1 delivered via small extracellular vesicles promotes gastric cancer cell stemnessEMBO reports 2021; 22(8) doi: 10.15252/embr.202050922
15
Zhishuo Zhang, Wenxia Zhao, Yiming Li, Yang Li, Hanzeng Cheng, Liyun Zheng, Xiaoyu Sun, Hao Liu, Rongguang Shao. YOD1 serves as a potential prognostic biomarker for pancreatic cancerCancer Cell International 2022; 22(1) doi: 10.1186/s12935-022-02616-9
16
Virender Kumar, Goutam Mondal, Paige Slavik, Satyanarayna Rachagani, Surinder K. Batra, Ram I. Mahato. Codelivery of Small Molecule Hedgehog Inhibitor and miRNA for Treating Pancreatic CancerMolecular Pharmaceutics 2015; 12(4): 1289 doi: 10.1021/mp500847s
17
Divya Singh, Ghanshyam Upadhyay, Rakesh K. Srivastava, Sharmila Shankar. Recent advances in pancreatic cancer: biology, treatment, and preventionBiochimica et Biophysica Acta (BBA) - Reviews on Cancer 2015; 1856(1): 13 doi: 10.1016/j.bbcan.2015.04.003
18
Tasuku Matsuoka, Masakazu Yashiro. Molecular targets for the treatment of pancreatic cancer: Clinical and experimental studiesWorld Journal of Gastroenterology 2016; 22(2): 776-789 doi: 10.3748/wjg.v22.i2.776
19
Deepanshi Dhar, Gagan Deep, Sushil Kumar, Michael F. Wempe, Komal Raina, Chapla Agarwal, Rajesh Agarwal. Bitter melon juice exerts its efficacy against pancreatic cancer via targeting both bulk and cancer stem cellsMolecular Carcinogenesis 2018; 57(9): 1166 doi: 10.1002/mc.22833
20
Fabio Grizzi, Sirio Fiorino, Dorina Qehajaj, Adele Fornelli, Carlo Russo, Dario de Biase, Michele Masetti, Laura Mastrangelo, Matteo Zanello, Raffaele Lombardi, Andrea Domanico, Esterita Accogli, Andrea Tura, Leonardo Mirandola, Maurizio Chiriva-Internati, Robert S. Bresalier, Elio Jovine, Paolo Leandri, Luca Di Tommaso. Computer-aided assessment of the extra-cellular matrix during pancreatic carcinogenesis: a pilot studyJournal of Translational Medicine 2019; 17(1) doi: 10.1186/s12967-019-1817-3
21
Yan-Jia Guo, Jing-Ru Pang, Yu Zhang, Zhong-Rui Li, Xiao-Lin Zi, Hong-Min Liu, Ning Wang, Li-Juan Zhao, Ya Gao, Bo Wang, Piet Herdewijn, Cheng-Yun Jin, Ying Liu, Yi-Chao Zheng. Neddylation-dependent LSD1 destabilization inhibits the stemness and chemoresistance of gastric cancerInternational Journal of Biological Macromolecules 2024; 254: 126801 doi: 10.1016/j.ijbiomac.2023.126801
22
Hsing-Yu Wu, Ming-Chen Yang, Li-Yun Ding, Ching S. Chen, Po-Chen Chu. p21-Activated kinase 3 promotes cancer stem cell phenotypes through activating the Akt-GSK3β-β-catenin signaling pathway in pancreatic cancer cellsCancer Letters 2019; 456: 13 doi: 10.1016/j.canlet.2019.04.026
23
Clifford C. Nwaeburu, Alia Abukiwan, Zhefu Zhao, Ingrid Herr. RETRACTED ARTICLE: Quercetin-induced miR-200b-3p regulates the mode of self-renewing divisions in pancreatic cancerMolecular Cancer 2017; 16(1) doi: 10.1186/s12943-017-0589-8
24
Cynthia I Tchio Mantho, Adriana Harbuzariu, Ruben R Gonzalez-Perez. Histone deacetylases, microRNA and leptin crosstalk in pancreatic cancerWorld Journal of Clinical Oncology 2017; 8(3): 178-189 doi: 10.5306/wjco.v8.i3.178
25
Anna Lyberopoulou, Gerasimos Aravantinos, Efstathios P. Efstathopoulos, Nikolaos Nikiteas, Penelope Bouziotis, Athina Isaakidou, Apostolos Papalois, Evangelos Marinos, Maria Gazouli, Javier S Castresana. Mutational Analysis of Circulating Tumor Cells from Colorectal Cancer Patients and Correlation with Primary Tumor TissuePLOS ONE 2015; 10(4): e0123902 doi: 10.1371/journal.pone.0123902
26
Jiang Ruibin, Cheng Guoping, Zheng Zhiguo, Ni Maowei, Wan Danying, Feng Jianguo, Gu Linhui. Establishment and Characterization of a Highly Metastatic Ovarian Cancer Cell LineBioMed Research International 2018; 2018: 1 doi: 10.1155/2018/3972534
27
Cristiana Tanase, Radu Albulescu, Monica Neagu. Proteomic Approaches for Biomarker Panels in CancerJournal of Immunoassay and Immunochemistry 2016; 37(1): 1 doi: 10.1080/15321819.2015.1116009
28
Koji Munakata, Mamoru Uemura, Shinji Tanaka, Kenji Kawai, Tomohiro Kitahara, Masaaki Miyo, Yoshihiro Kano, Shinpei Nishikawa, Takahito Fukusumi, Yusuke Takahashi, Taishi Hata, Junichi Nishimura, Ichiro Takemasa, Tsunekazu Mizushima, Masakazu Ikenaga, Takeshi Kato, Kohei Murata, John M. Carethers, Hirofumi Yamamoto, Yuichiro Doki, Masaki Mori. Cancer Stem-like Properties in Colorectal Cancer Cells with Low Proteasome ActivityClinical Cancer Research 2016; 22(21): 5277 doi: 10.1158/1078-0432.CCR-15-1945
29
Bai-Shun Wan, Ming Cheng, Ling Zhang. Insulin-like growth factor 2 mRNA-binding protein 1 promotes cell proliferation <i>via</i> activation of AKT and is directly targeted by microRNA-494 in pancreatic cancerWorld Journal of Gastroenterology 2019; 25(40): 6063-6076 doi: 10.3748/wjg.v25.i40.6063
30
Sirio Fiorino, Maria Letizia Bacchi-Reggiani, Chiara Birtolo, Giorgia Acquaviva, Michela Visani, Adele Fornelli, Michele Masetti, Andrea Tura, Stefano Sbrignadello, Fabio Grizzi, Federica Patrinicola, Matteo Zanello, Laura Mastrangelo, Raffaele Lombardi, Claudia Benini, Luca Di Tommaso, Arrigo Bondi, Francesco Monetti, Elena Siopis, Paolo Emilio Orlandi, Michele Imbriani, Carlo Fabbri, Silvia Giovanelli, Andrea Domanico, Esterita Accogli, Salomone Di Saverio, Daniela Grifoni, Vincenzo Cennamo, Paolo Leandri, Elio Jovine, Dario de Biase. Matricellular proteins and survival in patients with pancreatic cancer: A systematic reviewPancreatology 2018; 18(1): 122 doi: 10.1016/j.pan.2017.11.001
31
Xiaoxiao Liu, Zhang Li, Yuexiang Wang. Advances in Targeted Therapy and Immunotherapy for Pancreatic CancerAdvanced Biology 2021; 5(3) doi: 10.1002/adbi.201900236
32
Tatsuya Usui, Masashi Sakurai, Shuhei Enjoji, Hideyoshi Kawasaki, Koji Umata, Takashi Ohama, Nobuyuki Fujiwara, Ryotaro Yabe, Shunya Tsuji, Hideyuki Yamawaki, Shoichi Hazama, Hiroko Takenouchi, Masao Nakajima, Ryouichi Tsunedomi, Nobuaki Suzuki, Hiroaki Nagano, Koichi Sato. Establishment of a Novel Model for Anticancer Drug Resistance in Three-Dimensional Primary Culture of Tumor MicroenvironmentStem Cells International 2016; 2016: 1 doi: 10.1155/2016/7053872
33
Garima Kaushik, Parthasarathy Seshacharyulu, Sanchita Rauth, Palanisamy Nallasamy, Satyanarayana Rachagani, Rama Krishna Nimmakayala, Raghupathy Vengoji, Kavita Mallya, Ramakanth Chirravuri-Venkata, Amar B. Singh, Jason M. Foster, Quan P. Ly, Lynette M. Smith, Subodh M. Lele, Mokenge P. Malafa, Maneesh Jain, Moorthy P. Ponnusamy, Surinder K. Batra. Selective inhibition of stemness through EGFR/FOXA2/SOX9 axis reduces pancreatic cancer metastasisOncogene 2021; 40(4): 848 doi: 10.1038/s41388-020-01564-w
34
Vlad Herlea, Elena Stoica Mustafa, Andreea Cristina Iorgescu, Nicolae Catalin Pechianu, Dragos Cretoiu, Maria Sajin, Simona Olimpia Dima, Catalin Vasilescu, Cezar Stroescu, Constantin Ungureanu, Traian Dumitrascu, Vladislav Brasoveanu, Minerva Ghinescu, Irinel Popescu, Monica Neagu. A Morphological and Immunohistochemical Study of the Tumoral and Inflammatory Cells in Pancreatic Ductal AdenocarcinomaJournal of Immunology Research 2020; 2020: 1 doi: 10.1155/2020/6148286
35
Xiong Tian, Jing Zheng, Wanlan Mou, Guoguang Lu, Shuaishuai Chen, Juping Du, Yufen Zheng, Shiyong Chen, Bo Shen, Jun Li, Na Wang. Development and validation of a hypoxia-stemness-based prognostic signature in pancreatic adenocarcinomaFrontiers in Pharmacology 2022; 13 doi: 10.3389/fphar.2022.939542
36
Ingrid Garajová, Elisa Giovannetti, Sara Caponi, Annette van Zweeden, Godefridus J. Peters. MiRNAs and Their Interference with the Main Molecular Mechanisms Responsible for Drug Resistance in Pancreatic CancerCurrent Pharmacology Reports 2015; 1(4): 223 doi: 10.1007/s40495-014-0008-4
37
Chi‐Cheng Huang, Chien‐Min Lin, Yan‐Jiun Huang, Li Wei, Lei‐Li Ting, Chia‐Chun Kuo, Cheyu Hsu, Jeng‐Fong Chiou, Alexander T. H. Wu, Wei‐Hwa Lee. Garcinol downregulates Notch1 signaling via modulating miR‐200c and suppresses oncogenic properties of PANC‐1 cancer stem‐like cellsBiotechnology and Applied Biochemistry 2017; 64(2): 165 doi: 10.1002/bab.1446
38
Nikhil Tyagi, Saravanakumar Marimuthu, Arun Bhardwaj, Sachin K. Deshmukh, Sanjeev K. Srivastava, Ajay P. Singh, Steven McClellan, James E. Carter, Seema Singh. p-21 activated kinase 4 (PAK4) maintains stem cell-like phenotypes in pancreatic cancer cells through activation of STAT3 signalingCancer Letters 2016; 370(2): 260 doi: 10.1016/j.canlet.2015.10.028